Geneva Capital Management LLC Has $13.30 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Geneva Capital Management LLC boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 368.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 131,037 shares of the medical device company’s stock after acquiring an additional 103,069 shares during the period. Geneva Capital Management LLC owned 0.07% of Cooper Companies worth $13,295,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Cooper Companies by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 5,732,473 shares of the medical device company’s stock worth $2,169,397,000 after acquiring an additional 56,911 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Cooper Companies by 273.8% during the 1st quarter. Bank of New York Mellon Corp now owns 1,731,194 shares of the medical device company’s stock worth $175,647,000 after purchasing an additional 1,268,109 shares during the period. Congress Asset Management Co. MA increased its holdings in shares of Cooper Companies by 252.4% during the 1st quarter. Congress Asset Management Co. MA now owns 1,263,754 shares of the medical device company’s stock worth $128,220,000 after purchasing an additional 905,173 shares during the period. Victory Capital Management Inc. increased its holdings in shares of Cooper Companies by 16.5% during the 4th quarter. Victory Capital Management Inc. now owns 995,245 shares of the medical device company’s stock worth $376,641,000 after purchasing an additional 140,700 shares during the period. Finally, Jennison Associates LLC increased its holdings in shares of Cooper Companies by 200.2% during the 1st quarter. Jennison Associates LLC now owns 877,295 shares of the medical device company’s stock worth $89,010,000 after purchasing an additional 585,016 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 3.5 %

NASDAQ COO traded up $3.03 during trading hours on Thursday, hitting $88.58. The company’s stock had a trading volume of 2,861,257 shares, compared to its average volume of 1,116,017. The stock has a fifty day moving average of $92.08 and a 200 day moving average of $94.50. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $104.07. The firm has a market capitalization of $17.64 billion, a P/E ratio of 52.11, a PEG ratio of 2.12 and a beta of 0.98. The company has a quick ratio of 1.14, a current ratio of 1.95 and a debt-to-equity ratio of 0.34.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.83 by $0.02. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The firm had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. During the same quarter in the prior year, the firm earned $0.77 earnings per share. The business’s quarterly revenue was up 7.4% on a year-over-year basis. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on COO. JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $100.00 to $120.00 in a report on Wednesday, March 13th. Citigroup upped their target price on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Redburn Atlantic raised shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 target price on the stock in a research note on Tuesday, March 19th. Robert W. Baird upped their target price on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Finally, Piper Sandler reissued an “overweight” rating and issued a $115.00 target price on shares of Cooper Companies in a research note on Wednesday, July 3rd. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $111.42.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.